U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904677) titled 'Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer' on March 24.
Brief Summary: The goal of this observational study is to learn how well urinary proteins can predict treatment response in patients with locally advanced colorectal cancer (LACC) undergoing neoadjuvant therapy. The main question it aims to answer is:
Can urinary protein markers help predict and evaluate how patients with LACC respond to neoadjuvant therapy?
Participants diagnosed with LACC will provide urine samples before and after neoadjuvant therapy. These samples will be analyzed using 4D deep urinary proteomics and machi...